1 |
Reichenbach, H. and Hoefle, G. (1999) In Drue discovery from nature. Spinger, Berlin, Heidelberg, New York. pp. 149-179
|
2 |
Ahn, J. -W., Woo, S. -H., Lee, C. -0., Cho, K. -Y. and Kim, B. -S. (1999) KR025, a new cytotoxic compound from Myxococcus fulvus. J. Nat. Prod. 62, 495-496
DOI
ScienceOn
|
3 |
Reichenbach, H. (1996) Biologically active secondary metabolites from microorganism. GBF Scientific Annual Report, GBF, Braunschweig, Germany
|
4 |
Irschik, H., Jansen, R., Hoefle, G., Gerth, K. and Reichenbach, H. (1985) The corallopyronins, new inhibitors of bacterial RNA synthesis from myxobacteha. J. Antibiotics 38, 145-152
DOI
|
5 |
Yamanaka, S., Kawaguchi, A. and Komagata, K. (1987)Isolation and identification of myxobacteria. J. Gen. Appl. Microbiol. 33, 247-265
DOI
|
6 |
Iizuka, T, Jojima, Y, Fudou, R and Yamanaka S. (1998) Isolation of myxobacteha from the marine environment. FEMS Microbiot. Lett. 169, 317-322
DOI
ScienceOn
|
7 |
Reichenbach, H. and Hoefle, G. (1993) hi Myxobacteria II.American Society for Microbiology, Washington. pp. 347-397
|
8 |
Reichenbach, H. and Dworkin, M. (1992) In The Myxobacteria: the Prokaryotes (2nd ed.) Springer Verlag, New York. pp. 3416-3426
|
9 |
Sasse, R, Steinmetz, H., Heil, J., Hoefle, G. and Reichenbach, H. (2000) Tubulysins, new cytostatic peptides from Myxobacteha acting on microtubli. J. Antibiotics 53, 879-885
DOI
|
10 |
Cowden, C. J. and Paterson, I. (1997) Cancer drugs better than taxol? Nature 387, 238-239
DOI
ScienceOn
|
11 |
Rosenberg, E., Fyilovirch, S., Carmeli, S. and Kashman, Y. (1982) Chemical properties of M. xanthus antibiotic TA. J. Antibiotics 35, 788-793
DOI
|
12 |
Fudou, R., lizuka, T. and Yamanaka S. (2001) Haliangicin, a novel antifungal metabolite produced by a marine myxobactehum. J. Antibiotics 54, 149-152
DOI
|
13 |
JurIdewicz, E., Jansen, R., Kunze, B., rowitzsch-Kienast, W., Porche, E., Reichenbach, H., Hoefle, G. and Hunsmann, G. (1992) Three new potent HIV-l inhibitors from myxobacteha. Antivirat Chemistry & Chemotherapy 3, 189-193
DOI
|
14 |
Kunze, B., Jansen, R., Sasse, R, Hoefle, G. and Reichenbach, H. (1998) Apicularens A and B, new cytostatic macrolides from Chondmmyces sp. J. Antibiotics 51, 1075-1080
DOI
|
15 |
Kunze, B., Reichenbach, H., Augustiniak, H. and Hoefle, G (1982) Isolation and identification of althiomycin from C. fuscus. J. Antibiotics 35, 635-636.
DOI
|
16 |
Skehan, P., Storeng, R., Scudiero, D., Monks, A., McMahon, J., Vistica, D., Warren, J., Bokesch, H., Kenny, S. and Boyd, MR. (1990) New colorimethc cytotoxicity assay for anticancer drug screening. J. Nat. Cancer Inst. 82, 1107-1112
DOI
|
17 |
Onishi, N., Izaki, K. and Takahashi, H. (1984) A macrocydic antibiotic M-230B produced by M. xanthus. J. Antibiotics 37, 13-19
DOI
|
18 |
Wessjohann, L, (1997) Epothilones: Promising natural products with taxol-like activity. Angew. Chem. Int. Ed. Engl. 36, 715-71
DOI
ScienceOn
|
19 |
Trowitzsch-Kienast, W., Forche, E., Wray, V., Reichenbach, H., Jurkiewicz, E., Hunsmann, G. and Hoefle, G. (1992) Phenalamide, neue HIV-1 inhibitoren aus M. stipitatus Mx s40. Liebigs Ann. Chem. 1992, 659-664
|
20 |
Trowitzsch, W., Wray, V, Gerth, K. and Hoefle, G. (1982) Structure of myxovirescm A, a new macrocyclic antibiodc from gliding bacteiia. J. Chem. Soc. Chem. Commun. 1982, 1340-1342
|